An ASCRS presentation shows how fibrates and statins influence cataract diagnosis and surgery risk in distinct patient populations.
Opus Genetics and Viatris (through its affiliate) are parties to a global licensing agreement which provides for the development of phentolamine ophthalmic solution 0.75% and grants exclusive rights ...
If you've been thinking about ditching your glasses or contacts, you might be wondering: Is now a good time for LASIK surgery ...
OKYO Pharma Ltd (NASDAQ:OKYO), a clinical-stage biopharmaceutical company focused on treatments for neuropathic corneal pain ...
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the presentation of new scientific data and ...
Want More than a Routine Eye Visit? Here’s how Modern Treatment is Changing What Patients can Expect
Patients today often want more from an eye appointment than a quick prescription check or a simple confirmation that their ...
Gladys Khoza has regained her sight after a cataract surgery marathon in South Africa. She is one of 133 people who had free ...
Dell Laser Consultants is proud to be among the first practices in the United States to offer the TECNIS PureSee™ intraocular lens (IOL), the newest extended depth of focus (EDOF) lens from Johnson & ...
ZEISS Medical Technology will discuss and showcase latest workflow technologies at ASCRS 2026: Enhanced Cataract Workflow ...
Blue Fin Vision® has expanded the Bupa cataract pathway across three clinical sites, bringing consultant-delivered cataract care to insured ...
Founded in 2025, TrustShield24's pay-per-removal model now serves insurance and financial services clients across the ...
Controlled early clinical adoption begins across select U.S. centers as Iantrek accelerates toward commercialization of its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results